- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!
Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.
A bullish market and another quant upgrade could push BSX past our $31 target.
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
Canaccord is bullish on Edwards Lifescience stock.